Tonix Pharmaceuticals (NASDAQ:TNXP) Coverage Initiated by Analysts at StockNews.com

Stock analysts at StockNews.com assumed coverage on shares of Tonix Pharmaceuticals (NASDAQ:TNXP – Get Free Report) in a research report issued to clients and investors on Sunday. The firm set a “sell” rating on the stock. Separately, Dawson James began coverage on Tonix Pharmaceuticals in a research note on Wednesday, February 28th. They issued a […]

Leave a Reply

Your email address will not be published.

Previous post Reed’s (NYSE:REED) Coverage Initiated at StockNews.com
Next post Bright Horizons Family Solutions (NYSE:BFAM) Price Target Raised to $119.00 at JPMorgan Chase & Co.